Nektar Therapeutics Chief Legal Officer Mark A. Wilson to Depart; Elizabeth Zhang to Succeed

NEKTAR THERAPEUTICS

Mark A. Wilson will step down as Chief Legal Officer, effective December 31, 2025.
Elizabeth Zhang, Vice President of Legal and Corporate Counsel, will take over Wilson's responsibilities.
Zhang joined Nektar in 2021 and previously worked at Cravath, Swaine & Moore and Gibson, Dunn & Crutcher.
Zhang holds a BA from Harvard College, an MS from the University of Oxford, and a JD from Harvard Law School.
Wilson's departure is not the result of any disagreement with Nektar on operations, policies, or practices.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.